Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer

British Journal of Cancer

Volumn 107, Issue 9, 2012, Pages 1589-1594

  Mondul, A M ^a   Weinstein, S J ^a   Virtamo, J ^b   Albanes, D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

25 hydroxyvitamin D; case control study; urinary bladder neoplasms; vitamin D binding protein

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; VITAMIN D BINDING PROTEIN;

ADULT; ARTICLE; BLADDER CANCER; BLOOD SAMPLING; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK;

ALPHA-TOCOPHEROL; ANTICARCINOGENIC AGENTS; BETA CAROTENE; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; URINARY BLADDER NEOPLASMS; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84867897972     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.417     Document Type: Article

References (23)

1. Al-oanzi ZH, Tuck SP, Raj N, Harrop JS, Summers GD, Cook DB, Francis RM, Datta HK (2006) Assessment of vitamin D status in male osteoporosis. Clin Chem 52(2): 248-254
2. Bikle DD, Gee E (1989) Free, and not total, 1, 25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology 124(2): 649-654
3. Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P (1981) Influence of the vitamin D-binding protein on the serum concentration of 1, 25-dihydroxyvitamin D3. Significance of the free 1, 25-dihydroxyvitamin D3 concentration. J Clin Invest 67(3): 589-596
4. Brinkman MT, Karagas MR, Zens MS, Schned A, Reulen RC, Zeegers MP (2010) Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study. Cancer Causes Control 21(4): 609-619
5. Ersfeld DL, Rao DS, Body JJ, Sackrison Jr JL, Miller AB, Parikh N, Eskridge TL, Polinske A, Olson GT, MacFarlane GD (2004) Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 37(10): 867-874
6. Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, Hartge P, Hartmuller V, Harvey C, Hayes RB, Horst RL, Koenig KL, Kolonel LN, Laden F, McCullough ML, Parisi D, Purdue MP, Shu XO, Snyder K, Stolzenberg-Solomon RZ, Tworoger SS, Varanasi A, Virtamo J, Wilkens LR, Xiang YB, Yu K, Zeleniuch-Jacquotte A, Zheng W, Abnet CC, Albanes D, Bertrand K, Weinstein SJ (2010) Circulating 25-hydroxyvitamin D and the risk of rarer cancers: design and methods of the cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 172(1): 10-20
7. Giovannucci E (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16(2): 83-95
8. Haddad JG (1995) Plasma vitamin D-binding protein (Gc-globulin): multiple tasks. J Steroid Biochem Mol Biol 53(1-6): 579-582
9. Hofmann JN, Yu K, Horst RL, Hayes RB, Purdue MP (2010) Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 19(4): 927-931
10. Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79(3): 362-371
11. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59(4): 225-249
12. Konety BR, Lavelle JP, Pirtskalaishvili G, Dhir R, Meyers SA, Nguyen TS, Hershberger P, Shurin MR, Johnson CS, Trump DL, Zeidel ML, Getzenberg RH (2001) Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. J Urol 165(1): 253-258
13. Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J (2002) The Finnish Cancer Registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 41(4): 381-388
14. Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, Giovannucci E (2000) Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am J Epidemiol 152(12): 1145-1153
15. Mittal RD, Manchanda PK, Bhat S, Bid HK (2007) Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population. BJU Int 99(4): 933-937
16. Mondul AM, Weinstein SJ, Mannisto S, Snyder K, Horst RL, Virtamo J, Albanes D (2010) Serum vitamin D and risk of bladder cancer. Cancer Res 70(22): 9218-9223
17. NIoSaT (2009) Certificate of Analysis, Standard Reference Matiral 972 Vitamin D in Human Serum Vol. 2009. National institute of Standards and Techology: Gaithersburg, MD
18. Pike JW, Feldman D, Glorieux FH (1997) Vitamin D. Academic Press: San Diego
19. Powe CE, Ricciardi C, Berg AH, Erdenesanaa D, Collerone G, Ankers E, Wenger J, Karumanchi SA, Thadhani R, Bhan I (2011) Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 26(7 (1609-16)
20. Speeckaert M, Huang G, Delanghe JR, Taes YE (2006) Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 372(1-2): 33-42
21. The ATBC Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol 4(1): 1-10
22. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D (2012) Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res 72(5): 1190-1198
23. Willnow TE, Nykjaer A (2010) Cellular uptake of steroid carrier proteins-mechanisms and implications. Mol Cell Endocrinol 316(1): 93-102